ACTIVE

RevaTis

Financial year 2025 · Closed on 31/12/2025

Net result-620,7 k €-136,9 %over 1 year

Gross margin136,6 k €-77,5 %over 1 year

Equity2,6 M €+3,1 %over 1 year

Identity

Source · BCE/KBO

RevaTis is a Public limited company incorporated in 2013. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Marche-en-Famenne.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0541.682.642
Incorporation: 06/11/2013
Legal form: Public limited company
Registered office: Aye, Rue de la Science 8
6900 Marche-en-Famenne · WallonieSee on map
Contributed capital: 4 210 000,00 €
Latest accounts: 31/12/2025

Activities (NACE)

21201Manufacture of pharmaceutical preparations· main 21201Manufacture of pharmaceutical preparations 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods+2

Joint committees (1)

Signals

Solid equityHealthy social debts

Financials

Source · NBB, 12 filings

Trend over 12 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	136,6 k €	-77.5%	606,8 k €	+4.2%	582,3 k €	-15.4%	688,2 k €	+30.0%	529,5 k €
EBITDA	-280,7 k €	-345%	114,4 k €	-22.9%	148,3 k €	-57.3%	347,6 k €	+22.5%	283,8 k €
Operating result	-590,1 k €	-148%	-237,9 k €	-18.3%	-201,2 k €	-342%	83,2 k €	+24.2%	67 k €
Net result	-620,7 k €	-137%	-262 k €	-17.9%	-222,3 k €	-561%	48,3 k €	-17.6%	58,5 k €
Balance sheet
Equity	2,6 M €	+3.1%	2,5 M €	-9.6%	2,7 M €	+10.1%	2,5 M €	+64.0%	1,5 M €
Total assets	4,1 M €	+13.1%	3,6 M €	-5.1%	3,8 M €	+8.8%	3,5 M €	+32.8%	2,7 M €
Cash	371,7 k €	+45.5%	255,4 k €	-31.2%	371,3 k €	-18.2%	454,1 k €	+8.4%	418,9 k €
Debts	1,6 M €	+34.3%	1,2 M €	+6.2%	1,1 M €	+5.9%	1 M €	-8.9%	1,1 M €
Other
Workforce	–		5,7 ETP	+1.8%	5,6 ETP		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

12 active · 2 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Jacques KUYPERS	Directorsince 03/10/2013Managing director03/10/2013 → 2016 accountsended
Alexandre DALLEMAGNE	Directorsince 19/06/2020
Didier SERTEYN	Directorsince 31/10/2013Managing director31/10/2013 → 2023 accountsended
Jean-Claude HAVAUX	Directorsince 19/06/2020
Jean-Loup BLONDEAU	Directorsince 03/10/2013
Jean-Luc MARTIN	Directorsince 03/10/2013
Jean-Paul LACOMBLE	Directorsince 03/10/2013
Joseph MARTIAL	Directorsince 03/10/2013
LUXEMBOURG DEVELOPPEMENT EUROPE DEUX0670.937.716	Directorsince 19/06/2020
NOSHAQ PARTNERS0808.219.836Represented by frédéri Schybts	Directorsince 03/10/2013
Philippe NEVEN	Directorsince 03/10/2013
salamander U0640.885.928Represented by Jean-Claude DEDRY	Directorsince 23/01/2017

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
jean claude havaux	Directorlisted until the 2019 accounts
Herbert Osseman	Director10/03/2013 → 2018 accounts

Other companies at this address

Aye, Rue de la Science 8 6900 Marche-en-Famenne

Company	CBE no.
AGRICELLS● Active	0742.991.393
ALEXEIA● Active	1043.223.221
Association pour le développement des Productions Agroalimentaires de qualité● Active	0416.914.413
Association pour l'Usage et la Défense de l'Appellation Jambon d'Ardenne● Active	0457.901.762
ASSOCIATION POUR L'USAGE ET LA DEFENSE DU SAUCISSON D'ARDENNE● Active	0863.356.814
ATB THERAPEUTICS● Active	0677.980.015
Bureau d’Administration ATB THERAPEUTICS● Active	1031.100.991
CER-Groupe● Active	0420.654.158
INVESTY CORPORATE● Active	1008.960.841
LivingMed Biotech● Active	0748.443.684
Orgenesis (Belgium)● Bankrupt	0540.866.555
ORGENESIS SERVICES SRL● Bankrupt	0790.353.624
REVATIS VET● Active	1015.868.627
THERACELL ADVANCED BIOTECHNOLOGY (Belgium)● Active	0731.712.273

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Abridged model	Abridged model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/07/2026	12/11/2025	29/07/2024	12/07/2023	06/07/2022	31/08/2021
General meeting	12/06/2026	13/06/2025	14/06/2024	09/06/2023	10/06/2022	11/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 12 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	12/06/2026	28/07/2026	French	PDF
Abridged model	31/12/2024	13/06/2025	12/11/2025	French	PDF
Abridged model	31/12/2023	14/06/2024	29/07/2024	French	PDF
Micro model	31/12/2022	09/06/2023	12/07/2023	French	PDF
Micro model	31/12/2021	10/06/2022	06/07/2022	French	PDF
Micro model	31/12/2020	11/06/2021	31/08/2021	French	PDF
Micro model	31/12/2019	19/06/2020	09/07/2020	French	PDF
Micro model	31/12/2018	11/06/2019	01/07/2019	French	PDF
Micro model	31/12/2017	08/06/2018	05/07/2018	French	PDF
Micro model	31/12/2016	13/06/2017	12/07/2017	French	PDF
Abridged model	31/12/2015	07/06/2016	08/07/2016	French	PDF
Abridged model	31/12/2014	12/06/2015	15/07/2015	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

12 active · 2 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Jacques KUYPERS	Directorsince 03/10/2013Managing director03/10/2013 → 2016 accountsended
Alexandre DALLEMAGNE	Directorsince 19/06/2020
Didier SERTEYN	Directorsince 31/10/2013Managing director31/10/2013 → 2023 accountsended
Jean-Claude HAVAUX	Directorsince 19/06/2020
Jean-Loup BLONDEAU	Directorsince 03/10/2013
Jean-Luc MARTIN	Directorsince 03/10/2013
Jean-Paul LACOMBLE	Directorsince 03/10/2013
Joseph MARTIAL	Directorsince 03/10/2013
LUXEMBOURG DEVELOPPEMENT EUROPE DEUX0670.937.716	Directorsince 19/06/2020
NOSHAQ PARTNERS0808.219.836Represented by frédéri Schybts	Directorsince 03/10/2013
Philippe NEVEN	Directorsince 03/10/2013
salamander U0640.885.928Represented by Jean-Claude DEDRY	Directorsince 23/01/2017

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
jean claude havaux	Directorlisted until the 2019 accounts
Herbert Osseman	Director10/03/2013 → 2018 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Capital / shares17/07/2026
CAPITAL, ACTIONS
PDF
Mandates30/10/2025
DEMISSIONS, NOMINATIONS
PDF
Capital / shares23/09/2025
CAPITAL, ACTIONS
PDF
Mandates22/04/2025
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Capital / shares27/01/2025
CAPITAL, ACTIONS
PDF
Mandates22/11/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates07/08/2023
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Mandates26/07/2023
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings12 filings

Mandates

salamander U

LUXEMBOURG DEVELOPPEMENT EUROPE DEUX

NOSHAQ PARTNERS

Jean-Claude HAVAUX

Philippe NEVEN

Jean-Paul LACOMBLE

Jacques KUYPERS

Didier SERTEYN

Jean-Luc MARTIN

Joseph MARTIAL

Alexandre DALLEMAGNE

Jean-Loup BLONDEAU

Show the 2 other mandates

20132014201520162017201820192020202120222023202420252026

RevaTis

Aye, Rue de la Science 8, 6900 Marche-en-FamenneAvenue de l'Hopital 11, 4000 Liège

Director

DirectorManaging director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Aye, Rue de la Science 8, 6900 Marche-en-FamenneCurrent	accounts 2024 → 2025	Accounts 2025 · 2026-00343341
Avenue de l'Hopital 11, 4000 Liège	accounts 2021 → 2023	Accounts 2023 · 2024-00328583

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
RevaTisCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00343341

Events

2025
Annual accounts 2025-620,7 k €↓
2024
Annual accounts 2024-262 k €↓
2023
Annual accounts 2023-222,3 k €↓
2022
Annual accounts 202248,3 k €↓
2021
Annual accounts 202158,5 k €↓
2020
Annual accounts 2020281,5 k €↑
2019
Annual accounts 2019-304,6 k €↑
2018
Annual accounts 2018-352,2 k €↓
2017
Annual accounts 2017-35,6 k €↑
2016
Annual accounts 2016-162,8 k €↓
2015
Annual accounts 2015-133,6 k €↑
2014
Annual accounts 2014-192,3 k €
06/11/2013
IncorporationPublic limited company

RevaTis

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events